Difference between revisions of "VolCT - Group 2"
Jump to navigation
Jump to search
(New page: * Part 2 sets Standards for using Volumetric Imaging in Clinical Trials ** Determine level of performance adequate for using 3D volumetric analysis in a clinical trial ** Determine approp...) |
|||
| Line 3: | Line 3: | ||
** Determine appropriate imaging acquisition standards for use of 3D volumetric analysis | ** Determine appropriate imaging acquisition standards for use of 3D volumetric analysis | ||
** Determine what type of evaluations are necessary to validate the use of 3D volumetric imaging | ** Determine what type of evaluations are necessary to validate the use of 3D volumetric imaging | ||
| + | |||
| + | |||
| + | * Clinician's Perspective: Developing Quantitative Response Metrics for Lung Cancer | ||
| + | ** James L. Mulshine, MD | ||
Revision as of 16:09, 1 April 2009
- Part 2 sets Standards for using Volumetric Imaging in Clinical Trials
- Determine level of performance adequate for using 3D volumetric analysis in a clinical trial
- Determine appropriate imaging acquisition standards for use of 3D volumetric analysis
- Determine what type of evaluations are necessary to validate the use of 3D volumetric imaging
- Clinician's Perspective: Developing Quantitative Response Metrics for Lung Cancer
- James L. Mulshine, MD